{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:11:16Z","timestamp":1772442676058,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,2]]},"DOI":"10.7759\/cureus.104523","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:39:01Z","timestamp":1772440741000},"source":"Crossref","is-referenced-by-count":0,"title":["Atypical, Clinically Silent, Locally Advanced Pheochromocytoma Revealing Von Hippel-Lindau Type 2C Phenotype: A Case Report"],"prefix":"10.7759","author":[{"given":"Zineb","family":"Eddebbarh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"Serhane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zineb","family":"El Azime","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed Amine","family":"Essafi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hayat","family":"Aynaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Houda","family":"Salhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-025-02639-9","article-title":"Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies","volume":"48","author":"Vitturi G","year":"2025","unstructured":"Vitturi G, Crisafulli S, Alessi Y, et al.. Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies. J Endocrinol Invest. 2025, 48:2813-25. 10.1007\/s40618-025-02639-9","journal-title":"J Endocrinol Invest"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.07.027","article-title":"Diagnosis and management of pheochromocytomas and paragangliomas: a guide for the clinician","volume":"29","author":"Sharma S","year":"2023","unstructured":"Sharma S, Fishbein L. Diagnosis and management of pheochromocytomas and paragangliomas: a guide for the clinician. Endocr Pract. 2023, 29:999-1006. 10.1016\/j.eprac.2023.07.027","journal-title":"Endocr Pract"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3045","article-title":"Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome","volume":"100","author":"Aufforth RD","year":"2015","unstructured":"Aufforth RD, Ramakant P, Sadowski SM, et al.. Pheochromocytoma screening initiation and frequency in von Hippel-Lindau syndrome. J Clin Endocrinol Metab. 2015, 100:4498-504. 10.1210\/jc.2015-3045","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-021-02622-9","article-title":"Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas","volume":"23","author":"Garcia-Carbonero R","year":"2021","unstructured":"Garcia-Carbonero R, Matute Teresa F, Mercader-Cidoncha E, et al.. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas. Clin Transl Oncol. 2021, 23:1995-2019. 10.1007\/s12094-021-02622-9","journal-title":"Clin Transl Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12869","article-title":"Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma","volume":"285","author":"Muth A","year":"2019","unstructured":"Muth A, Crona J, Gimm O, et al.. Genetic testing and surveillance guidelines in hereditary pheochromocytoma and paraganglioma. J Intern Med. 2019, 285:187-204. 10.1111\/joim.12869","journal-title":"J Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14040917","article-title":"Pheochromocytomas and abdominal paragangliomas: a practical guidance","volume":"14","author":"Calissendorff J","year":"2022","unstructured":"Calissendorff J, Juhlin CC, Bancos I, Falhammar H. Pheochromocytomas and abdominal paragangliomas: a practical guidance. Cancers (Basel). 2022, 14:917. 10.3390\/cancers14040917","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb D","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, et al.. European Association of Nuclear Medicine Practice Guideline\/Society of Nuclear Medicine and Molecular Imaging Procedure Standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019, 46:2112-37. 10.1007\/s00259-019-04398-1","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-996-0027-6","article-title":"Hypertension in patients with pheochromocytoma","volume":"1","author":"Hanna NN","year":"1999","unstructured":"Hanna NN, Kenady DE. Hypertension in patients with pheochromocytoma. Curr Hypertens Rep. 1999, 1:540-5. 10.1007\/s11906-996-0027-6","journal-title":"Curr Hypertens Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-017-1310-9","article-title":"Routine genetic screening with a multi\u2011gene panel in patients with pheochromocytomas","volume":"59","author":"Sbardella E","year":"2018","unstructured":"Sbardella E, Cranston T, Isidori AM, et al.. Routine genetic screening with a multi\u2011gene panel in patients with pheochromocytomas. Endocrine. 2018, 59:175-82. 10.1007\/s12020-017-1310-9","journal-title":"Endocrine"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17061029","article-title":"Pheochromocytomas and paragangliomas-current management","volume":"17","author":"Brewczy\u0144ski A","year":"2025","unstructured":"Brewczy\u0144ski A, Kolasi\u0144ska-\u0106wik\u0142a A, Jab\u0142o\u0144ska B, Wyrwicz L. Pheochromocytomas and paragangliomas-current management. Cancers (Basel). 2025, 17:19-23. 10.3390\/cancers17061029","journal-title":"Cancers (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1433582","article-title":"Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment","volume":"15","author":"Saavedra TJS","year":"2024","unstructured":"Saavedra TJS, Nati-Castillo HA, Valderrama Cometa LA, et al.. Pheochromocytoma: an updated scoping review from clinical presentation to management and treatment. Front Endocrinol (Lausanne). 2024, 15:1433582. 10.3389\/fendo.2024.1433582","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/462247-atypical-clinically-silent-locally-advanced-pheochromocytoma-revealing-von-hippel-lindau-type-2c-phenotype-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T08:39:02Z","timestamp":1772440742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/462247-atypical-clinically-silent-locally-advanced-pheochromocytoma-revealing-von-hippel-lindau-type-2c-phenotype-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.104523","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3,2]]}}}